Actinium Pharmaceuticals, Inc.

AMEX:ATNM

Biotechnology

Healthcare
$1.64 +15.94%

+$0.22 today

Market cap
$51.56M
Beta
0.02
P/E (TTM)
4.4
EPS (TTM)
$0.36
52W Low $0.74High $1.74

Volume 0.18M

Average 0.15M

Balance Sheet

Inspect the capital base behind the business.

Assets

$51.77M

FY 2025 · Annual

-32.7% YoY

Liabilities

$43.94M

FY 2025 · Annual

-0.5% YoY

Equity

$7.83M

FY 2025 · Annual

-76.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents77.83M108.91M76.68M72.9M48M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets442K396K226K357K1.38M
Total Current Assets79.75M110.94M78.26M74.51M49.38M
Property, Plant & Equipment (Net)639K2.95M2.87M2.07M2.06M
Goodwill00000
Intangible Assets00000
Long-term Investments00313K324K0
Tax Assets00000
Other Non-current Assets0302K00335K
Total Non-current Assets639K3.25M3.18M2.39M2.39M
Total Assets80.39M114.19M81.45M76.9M51.78M
Account Payables5.54M10.13M7.95M7.57M0
Short-term Debt00541K0722K
Tax Payables00000
Deferred Revenue000035M
Other Current Liabilities998K000(27.75M)
Total Current Liabilities6.84M10.63M8.49M8.15M7.97M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)0035M35M35M
Other Non-current Liabilities035M000
Total Non-current Liabilities3K37.08M36.57M35.99M35.97M
Total Liabilities6.84M47.71M45.07M44.14M43.94M
Common Stock22K26K28K31K31K
Retained Earnings(255.75M)(288.77M)(337.58M)(375.83M)(409.71M)
Accumulated OCI(0)(0)00(20K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity73.55M66.48M36.38M32.76M7.83M
Total Debt310K2.58M2.11M1.57M1.69M
Net Debt(77.52M)(106.33M)(74.56M)(71.33M)(46.3M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$36.5M
Other Current$1.3M
Total Current Assets$37.7M
PP&E (Net)$700.0K
Other Non-current$1.7M
Total Non-current Assets$2.4M
Total Assets$40.2M

Analysis

Selected assets total $40.2M for Latest. The largest visible component is Cash & Equivalents at $36.5M, about 90.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 16, 2026
3Initial statement of beneficial ownershipOct 16, 2026
8-KCurrent reportOct 15, 2026
DEF 14ADEF 14A filingOct 15, 2026
ARSARS filingOct 15, 2026

How much cash does ATNM have?

Actinium Pharmaceuticals, Inc. (ATNM) reported $48.00M in cash and equivalents in fiscal 2025.

How much debt does ATNM carry?

Actinium Pharmaceuticals, Inc. (ATNM) reported $1.69M of total debt, with net debt of -$46.30M.